SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition
30 Octobre 2023 - 9:30PM
SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), today
announced the decision of its Board of Directors to cancel the
special cash dividend and stock dividend that it intended to make
to its common stockholders in connection with, and subject to, the
consummation of its planned acquisition of Lyneer Investments LLC
(“Lyneer”) and the disposition of its current business operations.
The Company had previously set September 26, 2023 as the record
date for the dividends (the “Record Date”). While the Record Date
had been set, the dividends had not yet been declared by the Board
nor had the amount of the proposed dividends been set. The
cancellation was due to significant logistical issues associated
with the proposed dividends that the Board believed could have
jeopardized the ability of the Company to complete its planned
acquisition. In lieu of making the cash dividend and the stock
dividend, the Company expects to make a settlement offer to all of
its stockholders as of the Record Date within 90 days of the
consummation of its acquisition of Lyneer to settle any claims for
failing to pay such dividends by issuing to such stockholders the
amount of cash and the number of shares of its common stock that
such stockholders would have received had such dividends been
declared and made.
About SeqLL Inc.
SeqLL is a technology company providing life
sciences instrumentation and research services in collaborative
partnerships aimed at the development of novel scientific assets
and intellectual property across multiple “omics” fields. The
Company leverages its expertise with the True Single Molecule
Sequencing (“tSMS®”) platform to empower scientists and researchers
with improved genetic tools to better understand the molecular
mechanisms of disease that is essential to the continued
development of new breakthroughs in genomic medicine, and that
hopefully address the critical concerns involved with today’s
precision medicine.
About Lyneer Investments
LLC
Lyneer, through its operating subsidiaries, primarily Lyneer
Staffing Solutions, is a national strategic staffing firm servicing
the commercial, professional, finance, direct placement, and
managed service provider verticals. Since its formation in 1995,
Lyneer has grown from a regional operation to a national staffing
firm with over 100 total locations and approximately 300 internal
employees across the United States. Its management believes
Lyneer is an industry leader in permanent, temporary and
temp-to-perm placement services in a wide variety of areas,
including, but not limited to, accounting & finance,
administrative & clerical, hospitality, IT, legal, light
industrial and medical fields.
Forward Looking Statements
This press release contains certain
forward-looking statements. Forward-looking statements are based on
the Company's current expectations and assumptions. The Private
Securities Litigation Reform Act of 1995 provides a safe-harbor for
forward-looking statements. These statements may be identified by
the use of forward-looking expressions, including, but not limited
to, “expect,” “anticipate,” “intend,” “plan,” “believe,”
“estimate,” “potential,” “predict,” “project,” “should,” “would”
and similar expressions and the negatives of those terms.
Forward-looking statements include statements made about the
proposed acquisition of Lyneer by the Company and the Company’s
expectations of commencing a settlement offer with its stockholders
of record as of the Record Date for failing to pay the special
stock and cash dividends contemplated by the original agreement for
the acquisition of Lyneer by the Company and the proposed
transactions contemplated by the Merger Agreement. Prospective
investors are cautioned not to place undue reliance on such
forward-looking statements, which speak only as of the date of this
presentation. The Company undertakes no obligation to publicly
update any forward-looking statement, whether as a result of new
information, future events or otherwise. Important factors that
could cause actual results to differ materially from those in the
forward-looking statements are set forth under the
caption “Risk Factors” in the Company’s filings with the Securities
and Exchange Commission, including its Annual Report on Form 10-K
for the year ended December 31, 2022 and its Quarterly Reports on
Form 10-Q for the quarters ended March 31, 2023 and June 30,
2023.
CONTACTS:
John W. Kennedy
Investor Relations
Tel: +1 (914) 727-7764
Email: jwkennedy@seqll.com
SeqLL (NASDAQ:SQL)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
SeqLL (NASDAQ:SQL)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025